391
A Study of DFRF4539A in Patients With Relapsed or Refractory Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:November 2, 2016Completed
Refractory Multiple Myeloma: 1473 Clinical Trials, Page 40 of 148
Hide Studies Not Open or Pending
392
A Study of Bevacizumab in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma (AMBER)
Condition(s):Multiple MyelomaLast Updated:June 14, 2017Completed
393
Pharmacokinetics Study of Oral Ixazomib (MLN9708) in Relapsed/Refractory Multiple Myeloma and Advanced Solid Tumors Participants With Normal Renal Function or Severe Renal Impairment
Condition(s):Multiple Myeloma; Advanced Solid TumorsLast Updated:June 10, 2019Completed
394
A Study of Tanespimycin (KOS-953) in Patients With Relapsed-refractory Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:December 7, 2015Completed
395
Weekly Bortezomib (Velcade) in the Treatment of Patients With Refractory Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:June 29, 2010Completed
396
Doxil® + Melphalan + Velcade (DMV) in Relapsed/Refractory Multiple Myeloma
Condition(s):Multiple Myeloma; Patient ParticipationLast Updated:June 17, 2020Terminated
397
Multinational Clinical Study Comparing Isatuximab, Pomalidomide, and Dexamethasone to Pomalidomide and Dexamethasone in Refractory or Relapsed and Refractory Multiple Myeloma Patients
Condition(s):Plasma Cell MyelomaLast Updated:April 21, 2023Active, not recruiting
398
A Study of Aplidin (Plitidepsin) 3 h iv in Subjects With Relapsing or Refractory Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:December 24, 2009Completed
399
MTD, Safety, and Efficacy of Pomalidomide (CC-4047) Alone or With Low-dose Dexamethasone in Patients With Relapsed and Refractory Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:April 27, 2016Completed
400
Phase 2 Clinical Trial of NPI-0052 in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:December 19, 2017Completed